We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.13 | 0.34% | 38.76 | 1,701 | 09:10:08 |
From Oct 2019 to Oct 2024
--GlaxoSmithKline PLC won't be pushed into a sale of its vaccines and pharmaceuticals business by activist U.S. hedge fund Elliott Management, The Times of London reports.
--Elliott isn't planning to agitate for reducing the pharmaceutical giant's 5 billion-pound ($7.06 billion) research and development budget and will back GlaxoSmithKline staying in the U.K., The Times says.
--Speculation had been raised by investors and analysts over Elliott's intentions after it was discovered in April that the activist fund had acquired a multi-billion pound stake in the company, The Times reports.
Full story: https://bit.ly/3i05I4y
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
May 27, 2021 01:26 ET (05:26 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
